Home / Health / Sickle Cell Patients Petition for Prescription Cost Exemption

Sickle Cell Patients Petition for Prescription Cost Exemption

Summary

  • Sickle cell disease causes debilitating symptoms
  • Patients face monthly costs for vital medication
  • Government says no plans to add SCD to exemption list
Sickle Cell Patients Petition for Prescription Cost Exemption

As of August 18th, 2025, sickle cell disease (SCD) patients in the UK are advocating for their condition to be added to the NHS prescription cost exemption list. SCD is a group of serious, lifelong health conditions that primarily affect individuals with African or Caribbean heritage, causing painful episodes, increased infection risk, and severe anemia.

Unlike treatments for other chronic illnesses, SCD medications are not currently exempt from prescription charges in England. This has led to concerns that "many patients may not be able to work but still face monthly costs for vital medication." However, the government maintains that "extensive arrangements" are already in place to ensure affordability, including exemptions for low-income individuals and prescription prepayment options.

Despite the petition's growing support, the government has stated there are "no current plans" to review the exemption list and include SCD. They argue that approximately 89% of prescriptions are already dispensed free of charge, and patients may qualify for other financial assistance schemes if needed.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.

FAQ

Sickle cell disease is a group of serious, lifelong health conditions that primarily affect the red blood cells, causing painful episodes, increased infection risk, and severe anemia.
Sickle cell patients in the UK are petitioning the government to add their condition to the NHS prescription cost exemption list, as they currently must pay monthly for essential medications to manage their disease.
The UK government has stated there are "no current plans" to review the exemption list and include sickle cell disease, arguing that extensive arrangements are already in place to ensure affordability of prescriptions.

Read more news on